Back to search
Non-proliferative Diabetic Retinopathy (NPDR)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-proliferative Diabetic Retinopathy (NPDR) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-proliferative Diabetic Retinopathy (NPDR) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Pilot, single-site, prospective study of QLS-111 0.015 % in subjects with NPDR, OAG or NTG
The goal of this clinical trial is to learn about the safety of the investigational medicinal product ANXV. It will also learn about how ANXV works to treat non…
The goal of this clinical trial is to evaluate whether remote ischemic conditioning (RIC) is a safe and effective treatment for non-proliferative diabetic retin…
The goal of this clinical trial is to evaluate the efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) of VX-01 as stand-alone treatment for Diabe…
The objective of this study is to evaluate the safety and efficacy of APX3330 to treat diabetic retinopathy (DR) and diabetic macular edema (DME).
The purpose of this Phase 2 study is comprised of two groups to evaluate the safety, tolerability, and efficacy of faricimab in patients with Non-Proliferative…